This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Output Catalog
ASAP is committed to accelerating the pace of discovery and informing a path to a cure for Parkinson’s disease through collaboration, research-enabling resources, and data sharing. We’ve created this catalog to showcase the research outputs and tools developed by ASAP-funded programs.
results for ""
Sort
Filter & Sort
-
Output Type
-
Program
-
CRN Team Name
-
Theme
iPSC QC (Adami et al, 2025)
Summary table and data from iPSC quality control experiments in Adami et al. 2025 are accessible for review.
Reply to: Is Gauchian genotyping of GBA1 variants reliable?
Summarizing a study by N. Tayebi et al. in Communications Biology, published in 2025.
Characterizing Parkinson’s Disease Clinical and Biomarker Interactions in REM Sleep Behavior Disorder
a-syn SAA positivity, DaT positivity, and hyposmia are highly associated with each other. MDS Prodromal PD Probability scores may be useful predictors of near-term progression, and thus as a stratification factor in clinical research study design
Inflamed Microglia like Macrophages in the Central Nervous System of Prodromal Parkinson′s Disease
We investigated the role of inflammation in the pathogenesis of prodromal PD performing single-cell RNAseq analysis of CSF and blood from 111 individuals.
Article: PINK1 deficiency rewires early immune responses in a mouse model of Parkinson’s disease triggered by intestinal infection
PINK1 KO mice show PD-like symptoms post intestinal infections, with myeloid cells dysregulation and T cell response early after infection. PINK1 plays a key role in gut immune functions linked to early PD mechanisms.
Supporting data for “PINK1 deficiency rewires early immune responses in a mouse model of Parkinson’s disease triggered by intestinal infection”
Data associated with “PINK1 deficiency rewires early immune responses in a mouse model of Parkinson’s disease triggered by intestinal infection”
Immunostaining and Western blot images
Raw immunostaining and western blot images included in Adami et al, 2025.
Baseline α–synuclein Seeding Activity and Disease Progression Code
The project analyzes baseline α-synuclein seeding activity and Parkinson's disease progression.
Soluble Immune Factor Profiles in Blood and CSF Associated with LRRK2 Mutations and Parkinson’s Disease
This preprint explores immune factors in Parkinson's disease linked to LRRK2 mutations. Serum showed elevated SDF-1 alpha and TNF-RII levels in LRRK2 carriers, while CSF had reduced immune markers. PD patients displayed reduced CSF inflammation.
Severe GBA1 variants drive the GBA-PD clinical phenotype: implications for counselling and clinical trials
Variants in the GBA1 gene are common genetic risk factors for Parkinson's disease. A study compared clinical phenotypes in GBA-PD and idiopathic PD patients, finding that only severe GBA-PD cases show a more severe clinical profile.
Exploring the relationship between GBA1 host genotype and gut microbiome in the GBA1L444P/WT mouse model: Implications for Parkinson disease pathogenesis
Heterozygous *GBA1* variants are common in Parkinson's disease. This study found no significant impact of the *GBA1* L444P variant on gut microbiome composition in mice, suggesting other factors may contribute to disease penetrance.
Immunohistochemistry (Brain organoids)
Protocol for preparing brain organoid slides and performing immunostainings to analyze protein expression and localization in the 3D model.
LINE-1 retrotransposons regulate the exit of human pluripotency and early brain development (Preprint)
Hominoid-specific L1 retrotransposons are expressed in human stem cells and organoids. Silencing L1s leads to changes in neural differentiation and organoid size, suggesting L1 involvement in central nervous system development.
(x6) GBA heterozygous and homozygous mutant fibroblast lines available to share
Cell lines deposited at ATCC used in a publication (10.1093/hmg/ddac233) include UCL-CTRL001, UCL-CTRL002, UCL-CTRL003, UCL-YCTRL001, UCL-E001K, UCL-N001S, and UCL-N002S, each with specific RRIDs.